Analyzing...
In continuation of our letter dated 13th January, 2025 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the transcript of the Conference call held on 29th January, 2025, on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended 31st December, 2024, is available on the Company’s website at https://www.piramalpharma.com/financial-reports Kindly take the above on record.
Thanking you,